IRIS
ROSSI, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.817
NA - Nord America 10.220
AS - Asia 6.506
SA - Sud America 1.342
AF - Africa 132
Continente sconosciuto - Info sul continente non disponibili 40
OC - Oceania 7
Totale 29.064
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.998
RU - Federazione Russa 2.902
IE - Irlanda 2.607
SG - Singapore 1.765
CN - Cina 1.727
HK - Hong Kong 1.389
DE - Germania 1.351
UA - Ucraina 1.032
BR - Brasile 1.025
SE - Svezia 965
VN - Vietnam 829
FI - Finlandia 603
IT - Italia 470
FR - Francia 399
IN - India 231
GB - Regno Unito 212
AR - Argentina 145
CA - Canada 113
BD - Bangladesh 112
KR - Corea 96
MX - Messico 72
ID - Indonesia 55
ZA - Sudafrica 54
PL - Polonia 49
JP - Giappone 48
EC - Ecuador 46
IQ - Iraq 41
NL - Olanda 40
EU - Europa 38
IR - Iran 37
CO - Colombia 36
TR - Turchia 32
PY - Paraguay 31
AT - Austria 29
ES - Italia 28
VE - Venezuela 27
BE - Belgio 26
CZ - Repubblica Ceca 24
PK - Pakistan 19
LT - Lituania 18
MA - Marocco 15
CL - Cile 14
UZ - Uzbekistan 14
EG - Egitto 12
KE - Kenya 11
MD - Moldavia 11
PH - Filippine 11
SA - Arabia Saudita 10
TW - Taiwan 10
IL - Israele 9
RO - Romania 9
DZ - Algeria 8
CR - Costa Rica 7
JM - Giamaica 7
MY - Malesia 7
OM - Oman 7
PE - Perù 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
CH - Svizzera 6
DK - Danimarca 6
HN - Honduras 6
KZ - Kazakistan 6
TN - Tunisia 6
AU - Australia 5
AZ - Azerbaigian 5
BG - Bulgaria 5
BJ - Benin 5
ET - Etiopia 5
GR - Grecia 5
HR - Croazia 5
KG - Kirghizistan 4
NP - Nepal 4
SN - Senegal 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BH - Bahrain 3
CY - Cipro 3
LB - Libano 3
MN - Mongolia 3
NI - Nicaragua 3
PA - Panama 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
GY - Guiana 2
JO - Giordania 2
MU - Mauritius 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TO - Tonga 2
BA - Bosnia-Erzegovina 1
Totale 29.047
Salva come PNG Salva come JPEG
Città #
Dublin 2.606
Jacksonville 1.900
Hong Kong 1.388
Dearborn 1.007
San Jose 943
Singapore 704
Wilmington 700
Ashburn 532
Beijing 505
Moscow 382
Chandler 380
Princeton 340
Lawrence 339
Ho Chi Minh City 291
Lauterbourg 290
San Mateo 256
Los Angeles 223
Hanoi 184
Andover 177
Ann Arbor 167
Buffalo 165
Council Bluffs 152
Piemonte 146
New York 106
São Paulo 97
Boardman 92
Seoul 90
Hefei 80
Dallas 76
Nanjing 72
Houston 71
Redondo Beach 71
Orem 66
Kunming 65
Guangzhou 64
Woodbridge 64
Santa Clara 62
Frankfurt am Main 56
Munich 50
Bremen 47
Norwalk 43
Tokyo 41
Montreal 40
Novara 40
Rio de Janeiro 39
Warsaw 39
Mexico City 35
Tianjin 35
Chennai 34
Denver 34
Helsinki 34
Atlanta 33
Da Nang 33
London 33
Toronto 33
Grafing 32
Hangzhou 32
Jinan 32
Düsseldorf 31
Seattle 31
Nuremberg 30
Milan 28
Haiphong 27
Nanchang 26
Belo Horizonte 25
Chicago 25
Phoenix 24
Poplar 24
Brussels 23
Stockholm 23
Johannesburg 22
Fairfield 19
Shanghai 19
Amsterdam 18
Biên Hòa 18
Thái Bình 18
Zanjan 18
Brno 17
Brooklyn 17
Curitiba 17
Manchester 17
Mumbai 17
Ninh Bình 17
Turku 17
Fuzhou 16
Guayaquil 16
San Francisco 16
Boston 15
Columbus 15
Dhaka 15
Las Vegas 15
Shenyang 15
Vercelli 15
Asunción 14
Manaus 14
Zhengzhou 14
Buenos Aires 13
Leawood 13
Paris 13
Porto Alegre 13
Totale 16.448
Salva come PNG Salva come JPEG
Nome #
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 177
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 175
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels 175
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 172
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 165
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 151
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 150
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 150
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 148
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 146
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 145
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 144
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 141
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 140
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 137
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 137
Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 136
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 135
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 135
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 134
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 133
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 133
The clinical implications of gene mutations in chronic lymphocytic leukaemia 133
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 133
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials 131
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 131
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 131
CLINICAL IMPLICATIONS OF THE MOLECULAR GENETICS OF CHRONIC LYMPHOCYTIC LEUKEMIA 131
Absence of NOTCH1 gene mutations in MALT lymphomas 129
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 128
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 125
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 123
The genetics of nodal marginal zone lymphoma 123
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study 123
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 123
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 122
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 122
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 121
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 121
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 121
Biology and treatment of Richter syndrome 120
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation 120
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 119
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 119
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 119
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 119
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 119
Extra-osseous Ewing sarcoma of the thyroid gland mimicking lymphoma recurrence: a case report 118
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 118
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia 117
GENETIC LESIONS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA CHEMO-REFRACTORINESS 116
Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients 116
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 116
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 115
ALTERAZIONI GENETICHE E INTERAZIONI CON IL MICROAMBIENTE NEI LINFOMI MALIGNI 115
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma 115
14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia 115
Clues to the pathogenesis of Waldenström Macroglobulinemia and IgM-MGUS provided by the analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors 115
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 115
MYC NETWORK MUTATIONS IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKAEMIA 114
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome 114
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. 113
AGGIORNAMENTI DI PATOGENESI MOLECOLARE DEI LINFOMI HIV-CORRELATI 113
Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia 113
BCL2 MUTATION SPECTRUM IN B-CELL NON-HODGKIN LYMPHOMAS AND PATTERNS ASSOCIATED WITH EVOLUTION OF FOLLICULAR LYMPHOMA 110
Simian Virus 40 (SV40) infection in lymphoproliferative disorders: A reappraisal based on five hundred cases 109
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia 108
Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance. 108
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation 107
Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients 107
Renal handling of monoclonal free light chains depends on fractional excretion: study on 1039 serum-urine paired samples of 187 patients 106
RICHTER SYNDROME: FROM MOLECULAR GENETIC TO THERAPEUTIC STRATEGIES 106
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia 106
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 106
Cryoglobulin-induced IL-1 beta gene expression and procytokine in monocytes from cryoglobulinemic patients. 105
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 105
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 104
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia 104
Genetic and phenotypic attributes of splenic marginal zone lymphoma 103
Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia 102
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression 102
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations 102
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukemia 101
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 101
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases. 100
Beta-2-microglobulin is an independent predictor of progression in asymptomatic multiple myeloma 100
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia 100
ASSOCIATION BETWEEN GENE AND MIRNA EXPRESSION PROFILES AND STEREOTYPED SUBSET #4 B-CELL RECEPTOR IN CHRONIC LYMPHOCYTIC LEUKEMIA. 99
GENETIC ABERRATIONS OF SIGNALING PATHWAYS IN LYMPHOMAGENESIS: REVELATIONS FROM NEXT GENERATION SEQUENCING STUDIES 99
Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome 99
The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment 98
ASPETTI MOLECOLARI DEI LINFOMI ASSOCIATI A HIV 97
HLA-G IS A COMPONENT OF THE CLL ESCAPE REPERTOIRE TO GENERATE IMMUNE SUPPRESSION: IMPACT OF HLA-G 14 BP (RS66554220) POLYMORPHISM 97
MOLECULAR PATHOPHYSIOLOGY OF INDOLENT LYMPHOMA 96
EARLY-STAGE DIFFUSE LARGE B CELL LYMPHOMA OF THE HEAD AND NECK: CLINICO-BIOLOGICAL CHARACTERIZATION AND 18 YEAR FOLLOW-UP OF 488 PATIENTS (IELSG 23 STUDY) 96
Richter syndrome and fludarabine: a controversial relationship 95
Saliva is a reliable and practical source of germline DNA for genome-wide studies in chronic lymphocytic leukemia 95
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 95
A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS 95
THE HOST GENETIC BACKGROUND OF DNA REPAIR MECHANISMS IS AN INDEPENDENT PREDICTOR OF PROGRESSION AND OVERALL SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA 95
Totale 11.981
Salva come PNG Salva come JPEG
Categoria #
all - tutte 151.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.123
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 0 11
2021/20221.959 24 12 284 193 154 15 209 31 154 57 363 463
2022/20234.202 356 132 213 60 154 321 98 177 2.532 5 95 59
2023/20241.217 74 68 82 22 238 15 256 29 5 5 81 342
2024/20253.295 63 10 68 40 93 218 279 246 1.221 418 103 536
2025/202611.028 425 392 1.002 1.744 753 776 1.646 1.916 853 835 558 128
Totale 29.429